{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T04:44:23Z","timestamp":1771562663484,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[1997,8,1]],"date-time":"1997-08-01T00:00:00Z","timestamp":870393600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[1997,8]]},"DOI":"10.1038\/nm0897-855","type":"journal-article","created":{"date-parts":[[2004,8,19]],"date-time":"2004-08-19T02:11:34Z","timestamp":1092881494000},"page":"855-859","source":"Crossref","is-referenced-by-count":212,"title":["Amyloid deposition is delayed in mice with targeted deletion of the serum amyloid P component gene"],"prefix":"10.1038","volume":"3","author":[{"given":"Marina","family":"Botto","sequence":"first","affiliation":[]},{"given":"Philip N.","family":"Hawkins","sequence":"additional","affiliation":[]},{"given":"Maria C.M.","family":"Bickerstaff","sequence":"additional","affiliation":[]},{"given":"Jeff","family":"Herbert","sequence":"additional","affiliation":[]},{"given":"Anne E.","family":"Bygrave","sequence":"additional","affiliation":[]},{"given":"Alan","family":"Mcbride","sequence":"additional","affiliation":[]},{"given":"Winston L.","family":"Hutchinson","sequence":"additional","affiliation":[]},{"given":"Glenys A.","family":"Tennent","sequence":"additional","affiliation":[]},{"given":"Mark J.","family":"Walportz","sequence":"additional","affiliation":[]},{"given":"Mark B.","family":"Pepys","sequence":"additional","affiliation":[]}],"member":"297","reference":[{"key":"BFnm0897855_CR1","first-page":"637","volume-title":"Samter's Immunologic Diseases","author":"MB Pepys","year":"1994","unstructured":"Pepys, M.B., Amyloidosis. in Samter's Immunologic Diseases. (eds. Frank, M.M., Austen, K.F., Claman, H.N. & Unanue, E.R.) 637\u2013655 (Little, Brown and Co., Boston, 1994)."},{"key":"BFnm0897855_CR2","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1056\/NEJM198006053022305","volume":"302","author":"GG Glenner","year":"1980","unstructured":"Glenner, G.G. Amyloid deposits and amyloidosis \u2014 the \u03b2-fibrilloses. I. N. Engl. j. Med. 302, 1283\u20131292 (1980).","journal-title":"N. Engl. j. Med."},{"key":"BFnm0897855_CR3","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1056\/NEJM198006123022403","volume":"302","author":"GG Glenner","year":"1980","unstructured":"Glenner, G.G. Amyloid deposits and amyloidosis \u2014 the \u03b2-fibrilloses. II. N. Engl. J. Med. 302, 1333\u20131 343 (1980).","journal-title":"N. Engl. J. Med."},{"key":"BFnm0897855_CR4","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/S0969-2126(96)00104-9","volume":"4","author":"CCF Blake","year":"1996","unstructured":"Blake, C.C.F. & Serpell, L.C. Synchrotron X-ray studies suggest that the core of the transthyretin amyloid fibril is a continuous \u03b2-sheet helix. Structure 4, 989\u2013998 (1996).","journal-title":"Structure"},{"key":"BFnm0897855_CR5","doi-asserted-by":"crossref","unstructured":"Pepys, M.B. et al. Amyloid P component. A critical review. Amyloid: Int. J. Exp. Clin. Invest. (in the press).","DOI":"10.3109\/13506129709003838"},{"key":"BFnm0897855_CR6","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/BF01254559","volume":"22","author":"PN Hawkins","year":"1995","unstructured":"Hawkins, P.N. & Pepys, M.B. Imaging amyloidosis with radiolabelled SAP. Eur. J. Nucl. Med. 22, 595\u2013599 (1995).","journal-title":"Eur. J. Nucl. Med."},{"key":"BFnm0897855_CR7","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/S0140-6736(84)90544-0","volume":"ii","author":"CRK Hind","year":"1984","unstructured":"Hind, C.R.K., Collins, P.M., Caspi, D., Baltz, M.L. & Pepys, M.B. Specific chemical dissociation of fibrillar and non-fibrillar components of amyloid deposits. Lancet ii, 376\u2013378 (1984).","journal-title":"Lancet"},{"key":"BFnm0897855_CR8","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/978-94-009-4309-4_5","volume-title":"Amyloidosis","author":"MB Pepys","year":"1986","unstructured":"Pepys, M.B. Amyloid P component: Structure and properties. in Amyloidosis. (eds. Marrink, J. & van Rijswijk, M.H.) 43\u201350 (Martinus Nijhoff, Dordrecht, the Netherlands, 1986)."},{"key":"BFnm0897855_CR9","doi-asserted-by":"publisher","first-page":"5602","DOI":"10.1073\/pnas.91.12.5602","volume":"91","author":"MB Pepys","year":"1994","unstructured":"Pepys, M.B. et al. Human serum amyloid P component is an invariant constituent of amyloid deposits and has a uniquely homogeneous glycostructure. Proc. Natl. Acad. Sci. USA 91, 5602\u20135606 (1994).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm0897855_CR10","doi-asserted-by":"publisher","first-page":"4299","DOI":"10.1073\/pnas.92.10.4299","volume":"92","author":"GA Tennent","year":"1995","unstructured":"Tennent, G.A., Lovat, L.B. & Pepys, M.B. Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer's disease and systemic amyloidosis. Proc. Natl. Acad. Sci. USA 92, 4299\u20134303 (1995).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm0897855_CR11","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1111\/j.1365-2249.1991.tb08166.x","volume":"84","author":"PN Hawkins","year":"1991","unstructured":"Hawkins, P.N., Tennent, G.A., Woo, P. & Pepys, M.B. Studies in vivo and in vitro of serum amyloid P component in normals and in a patient with AA amyloidosis. Clin. Exp. Immunol. 84, 308\u2013316 (1991).","journal-title":"Clin. Exp. Immunol."},{"key":"BFnm0897855_CR12","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1002\/pro.5560010602","volume":"1","author":"CM Kinoshita","year":"1992","unstructured":"Kinoshita, C.M. et al. A protease-sensitive site in the proposed Ca2+-binding region of human serum amyloid P component and other pentraxins. Protein Sci. 1, 700\u2013709 (1992).","journal-title":"Protein Sci."},{"key":"BFnm0897855_CR13","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1172\/JCI117474","volume":"94","author":"WL Hutchinson","year":"1994","unstructured":"Hutchinson, W.L., Noble, G.E., Hawkins, P.N. & Pepys, M.B. The pentraxins, C-reactive protein and serum amyloid P component, are cleared and catabolized by hepatocytes in vivo . J. Clin. Invest. 94, 1390\u20131396 (1994).","journal-title":"J. Clin. Invest."},{"key":"BFnm0897855_CR14","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/0009-8981(91)90090-Y","volume":"200","author":"SR Nelson","year":"1991","unstructured":"Nelson, S.R. et al. Serum amyloid P component in chronic renal failure and dialysis. Clin. Chim. Acta 200, 191\u2013200 (1991).","journal-title":"Clin. Chim. Acta"},{"key":"BFnm0897855_CR15","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.3181\/00379727-125-32292","volume":"125","author":"ES Cathcart","year":"1967","unstructured":"Cathcart, E.S., Wollheim, F.A. & Cohen, A.S. Immunoassay of P-component in amyloidotic sera. Proc. Soc. Exp. Biol. Med. 125, 1123\u20131125 (1967).","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"BFnm0897855_CR16","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1172\/JCI114917","volume":"86","author":"PN Hawkins","year":"1990","unstructured":"Hawkins, P.N., Wootton, R. & Pepys, M.B. Metabolic studies of radioiodinated serum amyloid P component in normal subjects and patients with systemic amyloidosis. J. Clin. Invest. 86, 1862\u20131869 (1990).","journal-title":"J. Clin. Invest."},{"key":"BFnm0897855_CR17","first-page":"355","volume":"39","author":"ML Baltz","year":"1980","unstructured":"Baltz, M.L. et al. Differences in the acute phase responses of serum amyloid P component (SAP) and C3 to injections of casein or bovine serum albumin in amyloid-susceptible and resistant mouse strains. Clin. Exp. Immunol. 39, 355\u2013360 (1980).","journal-title":"Clin. Exp. Immunol."},{"key":"BFnm0897855_CR18","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1084\/jem.171.4.1257","volume":"171","author":"JE Coe","year":"1990","unstructured":"Coe, J.E. & Ross, M.J. Amyloidosis and female protein in the Syrian hamster: Concurrent regulation by sex hormones. J. Exp. Med. 171, 1257\u20131267 (1990).","journal-title":"J. Exp. Med."},{"key":"BFnm0897855_CR19","first-page":"296","volume":"76","author":"F Snel","year":"1989","unstructured":"Snel, F. et al. Experimental amyloidosis in the hamster: Correlation between hamster female protein levels and amyloid deposition. Clin. Exp. Immunol. 76, 296\u2013300 (1989).","journal-title":"Clin. Exp. Immunol."},{"key":"BFnm0897855_CR20","first-page":"159","volume":"47","author":"DT Janigan","year":"1965","unstructured":"Janigan, D.T. Experimental amyloidosis: Studies with a modified casein method, casein hydrolysate and gelatin. Am. J. Pathol. 47, 159\u2013171 (1965).","journal-title":"Am. J. Pathol."},{"key":"BFnm0897855_CR21","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1172\/JCI108654","volume":"59","author":"MD Benson","year":"1977","unstructured":"Benson, M.D., Scheinberg, M.A., Shirahama, T., Cathcart, E.S. & Skinner, M. Kinetics of serum amyloid protein A in casein-induced murine amyloidosis. J. Clin. Invest. 59, 412\u2013417 (1977).","journal-title":"J. Clin. Invest."},{"key":"BFnm0897855_CR22","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1002\/art.1780301115","volume":"30","author":"D Caspi","year":"1987","unstructured":"Caspi, D. et al. Imaging of experimental amyloidosis with 131l-serum amyloid P component. Arthritis Rheum. 30, 1303\u20131306 (1987).","journal-title":"Arthritis Rheum."},{"key":"BFnm0897855_CR23","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1084\/jem.167.3.903","volume":"167","author":"PN Hawkins","year":"1988","unstructured":"Hawkins, P.N., Myers, M.J., Epenetos, A.A., Caspi, D. & Pepys, M.B. Specific localization and imaging of amyloid deposits in vivo using 123l-labeled serum amyloid P component. J. Exp. Med. 167, 903\u2013913 (1988).","journal-title":"J. Exp. Med."},{"key":"BFnm0897855_CR24","first-page":"685","volume-title":"Amyloid and Amyloidosis 1993","author":"DM Vigushin","year":"1994","unstructured":"Vigushin, D.M., Pepys, M.B. & Hawkins, P.N. Comparison of histology with SAP scintigraphy for evaluation of amyloidosis. in Amyloid and Amyloidosis 1993. (eds. Kisilevsky, R. et al.) 685\u2013687 (Parthenon Publishing, Pearl River, NY, 1994)."},{"key":"BFnm0897855_CR25","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/0272-6386(95)90647-9","volume":"26","author":"SY Tan","year":"1995","unstructured":"Tan, S.Y., Pepys, M.B. & Hawkins, P.N. Treatment of amyloidosis. Am. J. Kidney Dis. 26, 267\u2013285 (1995).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnm0897855_CR26","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3109\/13506129509031899","volume":"2","author":"R Kisilevsky","year":"1995","unstructured":"Kisilevsky, R., Gruys, E. & Shirahama, T. Does amyloid enhancing factor (AEF) exist? Is AEF a single biological entity? Amyloid: Int. J. Exp. Clin. Invest. 2, 128\u2013133 (1995).","journal-title":"Amyloid: Int. J. Exp. Clin. Invest."},{"key":"BFnm0897855_CR27","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1006\/bbrc.1994.1229","volume":"199","author":"K Ganowiak","year":"1994","unstructured":"Ganowiak, K., Hultman, P., Engstrom, U., Gustavsson, A. & Westermark, P. Fibrils from synthetic amyloid-related peptides enhance development of experimental AA amyloidosis in mice. Biochem. Biophys. Res. Commun. 199, 306\u2013312 (1994).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnm0897855_CR28","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/385787a0","volume":"385","author":"DR Booth","year":"1997","unstructured":"Booth, D.R. et al. Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis. Nature 385, 787\u2013793 (1997).","journal-title":"Nature"},{"key":"BFnm0897855_CR29","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/j.1365-2249.1990.tb03339.x","volume":"81","author":"PN Hawkins","year":"1990","unstructured":"Hawkins, P.N. & Pepys, M.B. A primed state exists in vivo following histological regression of amyloidosis. Clin. Exp. Immunol. 81, 325\u2013328 (1990).","journal-title":"Clin. Exp. Immunol."},{"key":"BFnm0897855_CR30","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1002\/art.1780360616","volume":"36","author":"PN Hawkins","year":"1993","unstructured":"Hawkins, P.N. et al. Serum amyloid P component scintigraphy and turnover studies for diagnosis and quantitative monitoring of AA amyloidosis in juvenile rheumatoid arthritis. Arthritis Rheum. 36, 842\u2013851 (1993).","journal-title":"Arthritis Rheum."},{"key":"BFnm0897855_CR31","first-page":"454","volume":"58","author":"F Coria","year":"1988","unstructured":"Coria, F. et al. Isolation and characterization of amyloid P component from Alzheimer's disease and other types of cerebral amyloidosis. Lab. Invest. 58, 454\u2013458 (1988).","journal-title":"Lab. Invest."},{"key":"BFnm0897855_CR32","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/BF00688180","volume":"78","author":"T Duong","year":"1989","unstructured":"Duong, T., Pommier, E.C. & Scheibel, A.B. Immunodetection of the amyloid P component in Alzheimer's disease. Acta Neuropathol. 78, 429\u2013437 (1989).","journal-title":"Acta Neuropathol."},{"key":"BFnm0897855_CR33","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1365-2990.1991.tb00714.x","volume":"17","author":"RN Kalaria","year":"1991","unstructured":"Kalaria, R.N., Galloway, P.G. & Perry, G. Widespread serum amyloid P immunore-activity in cortical amyloid deposits and the neurofibrillary pathology of Alzheimer's disease and other degenerative disorders. Neuropathol. Appl. Neurobiol. 17, 189\u2013201 (1991).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"BFnm0897855_CR34","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1007\/BF00687812","volume":"67","author":"T Kitamoto","year":"1985","unstructured":"Kitamoto, T., Tateishi, J., Hikita, K., Nagara, H. & Takeshita, I. A new method to classify amyloid fibril proteins. Acta Neuropathol. 67, 272\u2013278 (1985).","journal-title":"Acta Neuropathol."},{"key":"BFnm0897855_CR35","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/S0140-6736(05)61198-1","volume":"349","author":"J Fricker","year":"1997","unstructured":"Fricker, J. From mechanisms to drugs in Alzheimer's disease. The Lancet 349, 480 (1997).","journal-title":"The Lancet"},{"key":"BFnm0897855_CR36","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/373523a0","volume":"373","author":"D Games","year":"1995","unstructured":"Games, D. et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F \u03b2-amyloid precursor protein. Nature 373, 523\u2013527 (1995).","journal-title":"Nature"},{"key":"BFnm0897855_CR37","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1126\/science.274.5284.99","volume":"274","author":"K Hsiao","year":"1996","unstructured":"Hsiao, K. et al. Correlative memory deficits, A\u03b2 elevation, and amyloid plaques in transgenic mice. Science 274, 99\u2013102 (1996).","journal-title":"Science"},{"key":"BFnm0897855_CR38","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1038\/378779a0","volume":"378","author":"J Collinge","year":"1995","unstructured":"Collinge, J. et al. Unaltered susceptibility to BSE in transgenic mice expressing human prion protein. Nature 378, 779\u2013783 (1995).","journal-title":"Nature"},{"key":"BFnm0897855_CR39","first-page":"139","volume":"47","author":"MA Axelrad","year":"1982","unstructured":"Axelrad, M.A., Kisilevsky, R., Willmer, J., Chen, S.J. & Skinner, M. Further characterisation of amyloid-enhancing factor. Lab. Invest. 47, 139\u2013146 (1982).","journal-title":"Lab. Invest."},{"key":"BFnm0897855_CR40","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/278259a0","volume":"278","author":"MB Pepys","year":"1979","unstructured":"Pepys, M.B., Baltz, M., Comer, K., Davies, A.J.S. & Doenhoff, M. Serum amyloid P-component is an acute-phase reactant in the mouse. Nature 278, 259\u2013261 (1979).","journal-title":"Nature"},{"key":"BFnm0897855_CR41","first-page":"637","volume":"37","author":"MB Pepys","year":"1979","unstructured":"Pepys, M.B. Isolation of serum amyloid P component (protein SAP) in the mouse. Immunology 37, 637\u2013641 (1979).","journal-title":"Immunology"}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm0897-855","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm0897-855.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm0897-855.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T23:31:05Z","timestamp":1684452665000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm0897-855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,8]]},"references-count":41,"journal-issue":{"issue":"8","published-print":{"date-parts":[[1997,8]]}},"alternative-id":["BFnm0897855"],"URL":"https:\/\/doi.org\/10.1038\/nm0897-855","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,8]]}}}